PANAGENE is the worldwide supplier of PNA(DNA analogue) and a global leader in molecular diagnostics. PANAGENE's innovative platform technologies have been applied to identify personalized medicine for patients with lung(EGFR), colorectal(KRAS/NRAS), thyroid and skin(BRAF) cancer and to detect infectious diseases. PANAGENE has developed first in class detection kit in liquid biopsy in Korea and expanding its pipeline. With its unique technology, PANAGENE has enabled mass production of PNA since the beginning of the company. PANAGENE has exclusive sales rights for PNA and is sole provider for commercial use. All diagnostic products have applied PNA for high sensitivity, specificity and stability. Further information can be found at http://www.panagene.com.